Suppr超能文献

靛蓝和靛玉红通过增强肠道屏障功能治疗溃疡性结肠炎的联合治疗。

Combination Therapy with Indigo and Indirubin for Ulcerative Colitis via Reinforcing Intestinal Barrier Function.

机构信息

State Key Laboratory of Characteristic Chinese Drug Resources in Southwest China, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

Key Laboratory of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China.

出版信息

Oxid Med Cell Longev. 2023 Feb 14;2023:2894695. doi: 10.1155/2023/2894695. eCollection 2023.

Abstract

Indigo and indirubin, the active molecules of traditional Chinese medicine indigo naturalis, exert therapeutic activity for ulcerative colitis (UC). Indigo and indirubin are isomers and have distinctive profiles in anti-inflammation, immune regulation, intestinal microbiota regulation, oxidative stress regulation, and intestinal mucosal repair for UC treatment. Thus, exploring its combined administration's integrated advantages for UC is critical. This study is aimed at clarifying the effect and mechanisms of the combined administration of indigo and indirubin on colitis mouse models. The results showed that all the treatment groups could improve the disease symptoms, and the combined administration showed the best effect. Additionally, compared with indigo and indirubin alone, the combination group could significantly reinforce intestinal barrier function by increasing the expression of E-cadherin, occludin, ZO-1, and MUC2 and improving intestinal permeability. The treatment groups significantly improved the expression of cytokines, including TNF-, IFN-, IL-12, IL-23, and IL-17A, and indirubin presented the most potent anti-inflammatory effect. Furthermore, all the treatment groups reduced the infiltration of the immune cells in intestinal lamina propria and the production of ROS/RNS. Notably, indigo exhibited a more substantial capacity to regulate natural killer (NK) cells, ILC3, neutrophils, and dendritic cells, followed by the combination group and indirubin alone. Finally, all the treatment groups modulated intestinal microbiota composition, increased the proportion of beneficial microbiota, and decreased the proportion of microbiota. Our results indicated that indigo and indirubin synergistically reinforced the intestinal barrier function, which may be associated with integrating the indirubin anti-inflammatory and intestinal microbiota regulating strength and indigo immune and ROS/RNS regulation advantage.

摘要

靛蓝和靛玉红是中药青黛的活性成分,对溃疡性结肠炎(UC)具有治疗作用。靛蓝和靛玉红是同分异构体,在抗炎、免疫调节、肠道微生物群调节、氧化应激调节和肠道黏膜修复方面具有独特的特点,用于 UC 治疗。因此,探索其联合应用的综合优势对于 UC 至关重要。本研究旨在阐明靛蓝和靛玉红联合给药对结肠炎小鼠模型的作用和机制。结果表明,所有治疗组均可改善疾病症状,且联合给药效果最佳。此外,与靛蓝和靛玉红单独给药相比,联合组通过增加 E-钙黏蛋白、闭合蛋白、ZO-1 和 MUC2 的表达和改善肠道通透性,显著增强了肠道屏障功能。治疗组显著改善了 TNF-α、IFN-γ、IL-12、IL-23 和 IL-17A 等细胞因子的表达,靛玉红表现出最强的抗炎作用。此外,所有治疗组均减少了免疫细胞在肠固有层的浸润和 ROS/RNS 的产生。值得注意的是,靛蓝在调节自然杀伤(NK)细胞、ILC3、中性粒细胞和树突状细胞方面表现出更强的能力,其次是联合组和靛玉红单独给药。最后,所有治疗组均调节了肠道微生物群组成,增加了有益微生物群的比例,减少了微生物群的比例。我们的结果表明,靛蓝和靛玉红协同增强了肠道屏障功能,这可能与整合靛玉红的抗炎和肠道微生物群调节作用以及靛蓝的免疫和 ROS/RNS 调节优势有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b01/9943625/339d7e5ad7a3/OMCL2023-2894695.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验